New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 22, 2014
09:16 EDTPLXT, BEBE, MCD, LXK, ALSN, FB, HOG, ITW, RVNC, XRX, GSK, NVS, NFLX, FEYE, VRX, CMCSA, AGNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Netflix (NFLX), up 8%... Harley-Davidson (HOG), up 7%... PLX Technology (PLXT), up 8%... Illinois Tool (ITW), up 2.3%... Comcast (CMCSA), up 1%... McDonald's (MCD), up 0.6%. ALSO HIGHER: Allergan (AGN), up 17% after Valeant (VRX) confirms proposal to combine with the company for $48.30 and 0.83 shares of stock. Valeant is up 5% following its confirmation of the news that broke last night... GlaxoSmithKline (GSK), up 4.5% after agreeing to sell oncology products for $14.5B to Novartis (NVS) and buy Novartis' Vaccines business, currently excluding its flu business, for $7.1B plus royalties. Novartis shares trading in New York are also up 1% following the deals... Revance Therapeutics (RVNC), up 20% after announcing positive results from RT002 Phase 1/2 study... Facebook (FB), up 2% following upgrade at Credit Suisse. DOWN AFTER EARNINGS: Xerox (XRX), down 4%... Lexmark (LXK), down 4.8%. ALSO LOWER: Allison Transmission (ALSN), down 4% after filing to sell 25M shares for holders... FireEye (FEYE), down 2.9% after filing to sell 13.3M shares of common stock for holders... Bebe stores (BEBE), down 16% after reporting preliminary Q3 losses that were steeper than the consensus estimate.
News For AGN;VRX;NFLX;CMCSA;FEYE;NVS;GSK;HOG;MCD;XRX;FB;BEBE;RVNC;ALSN;PLXT;ITW;LXK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
June 23, 2015
08:03 EDTFBMondelez renews global strategic partnership with Facebook
Subscribe for More Information
07:25 EDTVRX, GSKPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
June 22, 2015
16:08 EDTALSND. E. Shaw reports 5% passive stake in Allison Transmission
Subscribe for More Information
16:00 EDTFBOptions Update; June 22, 2015
iPath S&P 500 VIX Short-Term Futures down 78c to 17.45. Option volume leaders: AAPL FB BAC CHK WMB BABA TWTR MU AMBA TSLA JPM
15:04 EDTCMCSAT-Mobile could abandon DISH for Comcast, Forbes contributor says
Subscribe for More Information
14:42 EDTFBOculus potential not reflected in Facebook's stock price, Piper Jaffray says
Subscribe for More Information
10:19 EDTFEYEAnalyst says get more selective on cybersecurity stocks
Subscribe for More Information
10:00 EDTFEYEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:40 EDTFEYE, FBActive equity options trading on open
Subscribe for More Information
07:49 EDTXRXXerox error-rate reduction not reflected in Street estimates, says Susquehanna
Subscribe for More Information
07:39 EDTNFLXNetflix price target raised to $950 on business momentum at BTIG
BTIG raised Buy rated Netflix's price target to $950 from $600 citing business model momentum. The firm's analyst believes Netflix can grow substantially beyond 50M domestic subs. In addition, as the MVPD bundle unravels, BTIG expects consumers will have money to spend on Netflix and other SVOD services. As the price/value of Netflix grows, the firm believes there is substantial upside potential to its ARPU estimates. BTIG expects Worldwide streaming subs to expand to over 108M by 2017, up from 101M, compared to 57M at year-end 2014. Furthermore, BTIG believes Netflix could reach 140M global subscribers by 2020.
07:31 EDTFBFacebook catching up to YouTube in video ads, Reuters says
Facebook (FB) is gaining market share on Google's (GOOG) YouTube in online video advertising, reports Reuters, citing a published Ampere Analysis report. Reference Link
07:01 EDTGSKPfizer to acquire Nimenrix, Mencevax from GlaxoSmithKline for $130M
Pfizer (PFE) announced that it has entered into an agreement with GlaxoSmithKline (GSK) to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130M. This transaction will add two high-quality and complementary vaccines to Pfizer’s portfolio, allowing the company to reach a broader global population. Nimenrix is a single dose meningococcal ACWY-TT conjugated vaccine designed to protect against Neisseria meningitidis, an uncommon but highly contagious disease that can lead to disability and death. Mencevax is a single-dose meningococcal ACWY unconjugated polysaccharide vaccine used to control outbreaks of meningococcal infection and for travelers to countries where the disease is endemic or highly epidemic. Pfizer does not expect this transaction to have any significant impact on its 2015 financial performance. The transaction is subject to customary closing conditions as well as regulatory approvals in several markets, and is expected to occur in the second half of 2015. Pfizer’s legal advisors for the transaction were Ropes & Gray and Clifford Chance.
07:01 EDTFEYEFireEye identifies Chinese group responsible for Federal hack, Re/code reports
Subscribe for More Information
06:59 EDTCMCSAComcast, NBCUniversal using cross-promotional strategy, NY Times says
Subscribe for More Information
06:25 EDTFBFacebook's CPO to outline new format for mobile advertising, WSJ reports
Subscribe for More Information
06:03 EDTFBFacebook price target raised to $120 from $92 at Piper Jaffray
Piper Jaffray analyst Gene Munster raised his price target for shares of Facebook to $120 and keeps an Overweight rating on the name. Facebook is the best play on the "next computer paradigm of virtual reality," Munster tells investors this morning in a research note. Oculus, the company's virtual reality technology, is an "insurance policy on the relevance of Facebook's social portfolio as technology shifts,” Munster writes. He believes the long-term value of technology is not reflected in the current share price. The social networking giant closed Friday down 39c to $82.51.
05:45 EDTFEYEFireEye downgraded to Neutral from Buy at UBS
UBS analyst Brent Thill downgraded FireEye (FEYE) to Neutral citing the stock's 70% rally year-to-date. Hill, however, raised his price target for name to $55 from $50. Shares of the cybersecurity provider closed Friday down 58c to $53.65. Hill also downgraded Symantec (SYMC) this morning to Sell. In the cybersecurity space, he keeps Buy ratings on Palo Alto Networks (PANW) and Fortinet (FTNT).
June 21, 2015
17:57 EDTCMCSARealD says 3D screens accounted for 47% of weekend 'Jurassic World' gross
Subscribe for More Information
16:21 EDTCMCSAUniversal's 'Jurassic World' leads U.S. weekend box office with $102M
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use